Cargando…

Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells

The safe utilization of induced pluripotent stem cell (iPSC) derivatives in clinical use is attributed to the complete elimination of the risk of forming teratomas after transplantation. The extent by which such a risk exists in immune-competent hosts is mostly unknown. Here, using humanized mice re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benabdallah, Basma, Désaulniers-Langevin, Cynthia, Colas, Chloé, Li, Yuanyi, Rousseau, Guy, Guimond, Jean V., Haddad, Elie, Beauséjour, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854018/ https://www.ncbi.nlm.nih.gov/pubmed/31787975 http://dx.doi.org/10.3389/fimmu.2019.02580

Ejemplares similares

Myogenic progenitor cells derived from human induced pluripotent stem cell are immune‐tolerated in humanized mice
por: Benabdallah, Basma, et al.
Publicado: (2020)

Autologous humanized mouse models of iPSC-derived tumors enable characterization and modulation of cancer-immune cell interactions
por: Moquin-Beaudry, Gaël, et al.
Publicado: (2022)

Targeted Gene Addition of Microdystrophin in Mice Skeletal Muscle via Human Myoblast Transplantation
por: Benabdallah, Basma F, et al.
Publicado: (2013)

Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells
por: Matsu-ura, Toru, et al.
Publicado: (2016)

Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders
por: Bedel, Aurelie, et al.
Publicado: (2016)

Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency
por: Pei, Yangli, et al.
Publicado: (2018)

Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis
por: Tabellini, Giovanna, et al.
Publicado: (2014)

The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation
por: Lezmi, Elyad, et al.
Publicado: (2020)

An Ethanol Extract of Coptidis rhizoma Induces Apoptotic Cell Death in Induced Pluripotent Stem Cells and Suppresses Teratoma Formation
por: Kim, Aeyung, et al.
Publicado: (2023)

Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis
por: Kim, Aeyung, et al.
Publicado: (2020)

Cisplatin induces differentiation in teratomas derived from pluripotent stem cells
por: Kurata, Atsushi, et al.
Publicado: (2021)

Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation
por: Park, Jongjin, et al.
Publicado: (2022)

Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas
por: Pappas, Matthew P., et al.
Publicado: (2022)

Models for Natural Killer Cell Repertoire Formation
por: Salmon-Divon, Mali, et al.
Publicado: (2003)

Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
por: Shankar, Keerthana, et al.
Publicado: (2020)

Immunoreactivity of Pluripotent Markers SSEA-5 and L1CAM in Human Tumors, Teratomas, and Induced Pluripotent Stem Cells
por: Cassidy, Linda, et al.
Publicado: (2013)

Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays
por: Bouma, Marga J., et al.
Publicado: (2017)

Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny
por: Gropp, Michal, et al.
Publicado: (2012)

The Co-Injection of Somatic Cells with Embryonic Stem Cells Affects Teratoma Formation and the Properties of Teratoma-Derived Stem Cell-Like Cells
por: Gong, Seung Pyo, et al.
Publicado: (2014)

miR-302 regulates pluripotency, teratoma formation and differentiation in stem cells via an AKT1/OCT4-dependent manner
por: Li, H-L, et al.
Publicado: (2016)

Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
por: Eguizabal, Cristina, et al.
Publicado: (2014)

Conditionally replicating adenovirus prevents pluripotent stem cell–derived teratoma by specifically eliminating undifferentiated cells
por: Mitsui, Kaoru, et al.
Publicado: (2015)

Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas
por: Kamada, Mizuna, et al.
Publicado: (2015)

TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells
por: Lelaidier, Martin, et al.
Publicado: (2015)

Fate Mapping of Human Embryonic Stem Cells by Teratoma Formation
por: Ritner, Carissa, et al.
Publicado: (2010)

In vivo reprogrammed pluripotent stem cells from teratomas share analogous properties with their in vitro counterparts
por: Choi, Hyun Woo, et al.
Publicado: (2015)

Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
por: Zhu, Huang, et al.
Publicado: (2019)

An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells
por: Hsu, Li-Jie, et al.
Publicado: (2021)

Generation of functional human T cell development in NOD/SCID/IL2rγ(null) humanized mice without using fetal tissue: Application as a model of HIV infection and persistence
por: Colas, Chloé, et al.
Publicado: (2023)

Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity
por: Cho, Seung-Ju, et al.
Publicado: (2015)

Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity
Publicado: (1985)

Selective apoptosis of pluripotent mouse and human stem cells by novel ceramide analogues prevents teratoma formation and enriches for neural precursors in ES cell–derived neural transplants
por: Bieberich, Erhard, et al.
Publicado: (2004)

Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas
por: Riegler, Johannes, et al.
Publicado: (2016)

TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas
por: Avior, Yishai, et al.
Publicado: (2015)

Photodynamic Approach for Teratoma-Free Pluripotent Stem Cell Therapy Using CDy1 and Visible Light
por: Cho, Seung-Ju, et al.
Publicado: (2016)

Natural killer cells and natural killer T cells in Lyme arthritis
por: Katchar, Kia, et al.
Publicado: (2013)

Generation of “Off-the-Shelf” Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
por: Zeng, Jieming, et al.
Publicado: (2017)

Using Advanced Cell Culture Techniques to Differentiate Pluripotent Stem Cells and Recreate Tissue Structures Representative of Teratoma Xenografts
por: Smith, L. A., et al.
Publicado: (2021)

Engraftment of Bone Marrow from Severe Combined Immunodeficient (SCID) Mice Reverses the Reproductive Deficits in Natural Killer Cell–deficient tgε26 Mice
por: Guimond, Marie-Josée, et al.
Publicado: (1998)

Themis2 regulates natural killer cell memory function and formation
por: Nabekura, Tsukasa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s966jt6k8ers7e2t66vr2kpkjq